Request for Covid-19 Impact Assessment of this Report
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world excipient market volume is estimated to reach 728.4 kilo tons by 2020, accounting for a revenue of $6.4 billion.
The world excipients market is driven by the increase in demand for oral solid pharmaceutical drugs and emergence of novel therapeutics on account of the upsurge in the number of pharmaceutical industries. The amalgamation of drug formulation and nanotechnology in pharmaceutical excipients have led to the development of nano-coated tablets, nano-derived liposomes, and vaccines. In addition, several companies have targeted the emerging economies for expansion of their plants for manufacturing pharmaceutical excipients, owing to cost-effective labor. However, higher production cost and stringent government regulations are likely to impede the market growth.
This report segments the world excipient market on the basis of type, function, and geography. Based on type, the market is segmented into organic and inorganic chemicals. Organic chemicals are further categorized into carbohydrates and petrochemicals. Based on function, the world market is classified into fillers and diluents, binders, coatings, flavoring agents, disintegrants, colorants, and others. The market has been analyzed on the basis of regions, namely North America, Europe, Asia-Pacific, and LAMEA. The North American excipient market is the leading revenue-generating region, owing to growing demand for solid oral drugs for the treatment of chronic diseases. However, the Asia-Pacific market is expected to register the highest CAGR, owing to low cost of raw materials and availability of cost-effective workforce.The key companies profiled in this report include Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., Evonik, Merck, J.M. Huber Corporation, Dow Chemicals Corporation, Merck Millipore, Croda International, and Archer Daniels Midland. These companies have adopted product launch as their key developmental strategy to expand their market presence.
KEY BENEFITS FOR STAKEHOLDERS:
KEY SEGMENTS:
Market By Type
Market By Function
Market By Geography
Table of Contents
CHAPTER 1 INTRODUCTION
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2020
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective
3.4 Nanotechnology in excipient
3.5 Emerging role of excipient in the pharmaceutical industry
3.6 Porters five force analysis
3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players
3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials
3.9.1 A study of insulin lispro with biochaperone excipient in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study
3.10 Market dynamics
3.10.1 Drivers
3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings
3.10.2 Restraints
3.10.2.1 Supply chain issues
3.10.2.2 Segregated excipient market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment
3.10.3 Opportunities
3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development
CHAPTER 4 WORLD EXCIPIENT MARKET, BY TYPE, 2014-2020
4.1 Overview
4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.2 Inorganic Chemicals
4.2.1 Market size and forecast
4.2.2 Calcium Phosphates
4.2.2.1 Market size and forecast
4.2.3 Calcium Carbonate
4.2.3.1 Market size and forecast
4.2.4 Calcium Sulfate
4.2.4.1 Market size and forecast
4.2.5 Halites
4.2.5.1 Market size and forecast
4.2.6 Metallic Oxides
4.2.6.1 Market size and forecast
4.2.7 Others
4.2.7.1 Market size and forecast
4.3 Organic chemicals
4.3.1 Market size and forecast
4.3.2 Carbohydrates
4.3.2.1 Market size and foreast
4.3.2.2 Sugars
4.3.2.2.1 MARKET SIZE AND FORECAST
4.3.2.3 Starch
4.3.2.3.1 MARKET SIZE AND FORECAST
4.3.2.4 Cellulose
4.3.2.4.1 MARKET SIZE AND FORECAST
4.3.3 Petrochemicals
4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)
4.3.3.2.1 MARKET SIZE AND FORECAST
4.3.3.3 Povidones Polymers
4.3.3.3.1 MARKET SIZE AND FORECAST
4.3.3.4 Mineral Hydrocarbons
4.3.3.4.1 MARKET SIZE AND FORECAST
4.3.3.5 Oleochemicals
4.3.3.5.1 MARKET SIZE AND FORECAST
4.3.3.6 Gelatin (Proteins)
4.3.3.6.1 MARKET SIZE AND FORECAST
CHAPTER 5 WORLD EXCIPIENT MARKET, BY FUNCTION, 2014-2020
5.1 Overview
5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast
5.2 Fillers & Diluents
5.2.1 Market size and forecast
5.3 Suspension & viscosity agents
5.3.1 Market size and forecast
5.4 Binders
5.4.1 Market size and forecast
5.5 Coatings
5.5.1 Market size and forecast
5.6 Flavoring agents
5.6.1 Market size and forecast
5.7 Disintegrants
5.7.1 Market size and forecast
5.8 Colorants
5.8.1 Market size and forecast
5.9 Others
5.9.1 Lubricants & Glidants
5.9.1.1 Role of lubricants
5.9.2 Preservatives
5.9.3 Market size and forecast
CHAPTER 6 WORLD EXCIPIENT MARKET, BY GEOGRAPHY, 2014-2020
6.1 Overview
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Ashland Inc.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.
7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement
7.1.5 SWOT analysis of Ashland Inc.
7.2 Associated British Food Plc
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc
7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance
7.2.5 SWOT analysis of Associated British Food Plc
7.3 AkzoNobel
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel
7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition
7.3.4 SWOT analysis of AkzoNobel
7.4 Evonik
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik
7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion
7.4.5 SWOT analysis of Evonik
7.5 J.M. Huber Corporation
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation
7.5.3.1 Primary Strategies: expansion
7.5.4 SWOT analysis of J.M. Huber Corporation
7.6 Archer Daniels Midland
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland
7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations
7.6.4 SWOT analysis of Archer Daniels Midland
7.7 BASF
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF
7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition
7.7.4 SWOT analysis of BASF
7.8 Dow Chemical Corporation
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation
7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches
7.8.5 SWOT analysis of Dow Chemical Corporation
7.9 Merck Millipore
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore
7.9.4.1 Primary Strategies: Product Launch
7.9.5 SWOT analysis of Merck Millipore
7.10 Croda International plc
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.
7.10.4.1 Primary Strategies: approval and expansion
7.10.5 SWOT analysis of Croda International plc.
List of Figures
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 WORLD EXCIPIENT MARKET SEGMENTATION
FIG. 5 TOP INVESTMENT POCKETS IN THE WORLD EXCIPIENT MARKET, 2014
FIG. 6 DISTRIBUTION OF TOP WINNING STRATEGIES
FIG. 7 PORTERS FIVE FORCE ANALYSIS OF WORLD EXCIPIENT MARKET
FIG. 8 VALUE CHAIN ANALYSIS OF WORLD EXCIPIENT MARKET
FIG. 9 PATENT ANALYSIS OF WORLD EXCIPIENT MARKET FROM 2014-2015
FIG. 10 TOP FACTORS IMPACTING WORLD EXCIPIENT MARKET, 2014-2020
FIG. 11 KEY FINANCIALS OF ASHLAND INC. BY GEOGRAPHY (2014)
FIG. 12 KEY FINANCIALS OF ASHLAND INC. BY REPORTABLE SEGMENTS (2014)
FIG. 13 SWOT ANALYSIS OF ASHLAND INC.
FIG. 14 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY GEOGRAPHY (2015)
FIG. 15 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY REPORTABLE SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF ASSOCIATED BRITISH FOOD PLC
FIG. 17 KEY FINANCIALS OF AKZONOBEL BY GEOGRAPHY (2014)
FIG. 18 KEY FINANCIALS OF AKZONOBEL BY SEGMENTS (2014)
FIG. 19 SWOT ANALYSIS OF AKZONOBEL
FIG. 20 KEY FINANCIALS OF EVONIK BY BUSINESSES (2014)
FIG. 21 KEY FINANCIALS OF EVONIK BY SEGMENTS (2014)
FIG. 22 SWOT ANALYSIS OF EVONIK
FIG. 23 SWOT ANALYSIS OF J.M. HUBER CORPORATION
FIG. 24 KEY FINANCIALS OF ARCHER DANIELS MIDLAND BY BUSINESSES (2014)
FIG. 25 SWOT ANALYSIS OF ARCHER DANIELS MIDLAND
FIG. 26 KEY FINANCIALS OF BASF BY GEOGRAPHY (2014)
FIG. 27 KEY FINANCIAL OF BASF BY SALES BY REPORTABLE SEGMENTS (2014)
FIG. 28 SWOT ANALYSIS OF BASF
FIG. 29 KEY FINANCIALS OF DOW CHEMICAL CORPORATION BY GEOGRAPHY (2014)
FIG. 30 KEY FINANCIAL OF DOW CHEMICAL CORPORATION BY REPORTABLE SEGMENTS (2014)
FIG. 31 SWOT ANALYSIS OF DOW CHEMICAL CORPORATION
FIG. 32 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHY (2014)
FIG. 33 FINANCIAL REVENUES OF MERCK MILLIPORE BY BUSINESS SEGMENT (2014)
FIG. 34 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 35 FINANCIAL REVENUES OF CRODA BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES OF CRODA BY BUSINESS SEGMENT (2014)
FIG. 37 SWOT ANALYSIS OF CRODA
List of Tables
TABLE 1 WORLD EXCIPIENT BASE CASE SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020 2025 (TONNES)
TABLE 2 WORLD EXCIPIENT BASE CASE SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020 2025 ($MILLION)
TABLE 3 WORLD EXCIPIENT RAPID GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020 2025 (TONNES)
TABLE 4 WORLD EXCIPIENT RAPID GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020 2025 ($MILLION)
TABLE 5 WORLD EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020 2025 (TONNES)
TABLE 6 WORLD EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020 2025 ($MILLION)
TABLE 7 WORLD EXCIPIENT MARKET VOLUME, BY TYPE, 20142020 (TONNES)
TABLE 8 WORLD EXCIPIENT MARKET REVENUE, BY TYPE, 20142020 ($MILLION)
TABLE 9 WORLD INORGANIC CHEMICAL EXCIPIENT MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 10 WORLD CALCIUM PHOSPHATE EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 WORLD CALCIUM CARBONATE EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 12 WORLD CALCIUM SULFATE EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 13 WORLD HALITES EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 WORLD METALLIC OXIDES EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 WORLD ORGANIC CHEMICAL EXCIPIENT MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 17 WORLD CARBOHYDRATES EXCIPIENT MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 18 WORLD CARBOHYDRATES EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 WORLD SUGARS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 20 WORLD SUGARS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 21 WORLD CELLULOSE EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 22 WORLD PETROCHEMICAL EXCIPIENT MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 23 WORLD PETROCHEMICAL EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 24 WORLD GLYCOLS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 25 FEATURES AND BENEFITS OF POVIDONES POLYMERS
TABLE 26 WORLD POVIDONE POLYMERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 27 WORLD MINERAL HYDROCARBONS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 28 WORLD OLEOCHEMICALS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 29 WORLD GELATIN EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 30 WORLD EXCIPIENT MARKET VOLUME, BY FUNCTION, 2014-2020, (TONNES)
TABLE 31 WORLD EXCIPIENT MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 32
TABLE 33 WORLD FILLERS& DILUENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 WORLD SUSPENSION & VISCOSITY AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 35 TYPES OF BINDERS USED AS EXCIPIENTS
TABLE 36 COMMON TYPE OF BINDERS USED IN THE MARKET
TABLE 37 WORLD BINDERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 38 WORLD COATINGS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 39 WORLD FLAVORING AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 WORLD DISINTEGRANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 41 WORLD COLORANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 43 WORLD EXCIPIENT MARKET VOLUME, BY GEOGRAPHY, 2014-2020, (TONNES)
TABLE 44 WORLD EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 45 NORTH AMERICA EXCIPIENT MARKET REVENUE, BY FUNCTIONS, 2014-2020, ($MILLION)
TABLE 46 EUROPE EXCIPIENT MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 47 ASIA PACIFIC EXCIPIENT MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 48 LAMEA EXCIPIENT MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 49 ASHLAND INC. COMPANY SNAPSHOT
TABLE 50 ASSOCIATED BRITISH FOOD PLC COMPANY SNAPSHOT
TABLE 51 AKZONOBEL COMPANY SNAPSHOT
TABLE 52 EVONIK COMPANY SNAPSHOT
TABLE 53 J.M. HUBER CORPORATION COMPANY SNAPSHOT
TABLE 54 ARCHER DANIELS MIDLAND COMPANY SNAPSHOT
TABLE 55 BASF COMPANY SNAPSHOT
TABLE 56 DOW CHEMICAL CORPORATION COMPANY SNAPSHOT
TABLE 57 SNAPSHOT OF MERCK MILLIPORE
TABLE 58 SNAPSHOT OF CRODA
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...